IBDEI0HI ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23529,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23529,1,2,0)
 ;;=2^20550
 ;;^UTILITY(U,$J,358.3,23529,1,3,0)
 ;;=3^Inj Tendon Sheath/Ligamnt
 ;;^UTILITY(U,$J,358.3,23530,0)
 ;;=20552^^148^1339^9^^^^1
 ;;^UTILITY(U,$J,358.3,23530,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23530,1,2,0)
 ;;=2^20552
 ;;^UTILITY(U,$J,358.3,23530,1,3,0)
 ;;=3^Trigger Inj Point 1 or 2
 ;;^UTILITY(U,$J,358.3,23531,0)
 ;;=20553^^148^1339^10^^^^1
 ;;^UTILITY(U,$J,358.3,23531,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23531,1,2,0)
 ;;=2^20553
 ;;^UTILITY(U,$J,358.3,23531,1,3,0)
 ;;=3^Trigger Inj Points 3+
 ;;^UTILITY(U,$J,358.3,23532,0)
 ;;=J1600^^148^1340^1^^^^1
 ;;^UTILITY(U,$J,358.3,23532,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23532,1,2,0)
 ;;=2^J1600
 ;;^UTILITY(U,$J,358.3,23532,1,3,0)
 ;;=3^Gold Inj up to 50mg
 ;;^UTILITY(U,$J,358.3,23533,0)
 ;;=J9250^^148^1340^3^^^^1
 ;;^UTILITY(U,$J,358.3,23533,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23533,1,2,0)
 ;;=2^J9250
 ;;^UTILITY(U,$J,358.3,23533,1,3,0)
 ;;=3^Methotrexate Inj 5mg
 ;;^UTILITY(U,$J,358.3,23534,0)
 ;;=96372^^148^1340^4^^^^1
 ;;^UTILITY(U,$J,358.3,23534,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23534,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,23534,1,3,0)
 ;;=3^Ther/Proph Inj, SC/IM
 ;;^UTILITY(U,$J,358.3,23535,0)
 ;;=96374^^148^1340^5^^^^1
 ;;^UTILITY(U,$J,358.3,23535,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23535,1,2,0)
 ;;=2^96374
 ;;^UTILITY(U,$J,358.3,23535,1,3,0)
 ;;=3^Ther/Proph/Diag Inj IV
 ;;^UTILITY(U,$J,358.3,23536,0)
 ;;=96375^^148^1340^6^^^^1
 ;;^UTILITY(U,$J,358.3,23536,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23536,1,2,0)
 ;;=2^96375
 ;;^UTILITY(U,$J,358.3,23536,1,3,0)
 ;;=3^Ther/Proph Inj IV Ea Addl
 ;;^UTILITY(U,$J,358.3,23537,0)
 ;;=J3301^^148^1340^2^^^^1
 ;;^UTILITY(U,$J,358.3,23537,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23537,1,2,0)
 ;;=2^J3301
 ;;^UTILITY(U,$J,358.3,23537,1,3,0)
 ;;=3^Kenalog Inj 10mg
 ;;^UTILITY(U,$J,358.3,23538,0)
 ;;=99201^^149^1341^1
 ;;^UTILITY(U,$J,358.3,23538,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23538,1,1,0)
 ;;=1^Problem Focused
 ;;^UTILITY(U,$J,358.3,23538,1,2,0)
 ;;=2^99201
 ;;^UTILITY(U,$J,358.3,23539,0)
 ;;=99202^^149^1341^2
 ;;^UTILITY(U,$J,358.3,23539,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23539,1,1,0)
 ;;=1^Expanded Problem Focused
 ;;^UTILITY(U,$J,358.3,23539,1,2,0)
 ;;=2^99202
 ;;^UTILITY(U,$J,358.3,23540,0)
 ;;=99203^^149^1341^3
 ;;^UTILITY(U,$J,358.3,23540,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23540,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,23540,1,2,0)
 ;;=2^99203
 ;;^UTILITY(U,$J,358.3,23541,0)
 ;;=99204^^149^1341^4
 ;;^UTILITY(U,$J,358.3,23541,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23541,1,1,0)
 ;;=1^Comprehensive-Moderate
 ;;^UTILITY(U,$J,358.3,23541,1,2,0)
 ;;=2^99204
 ;;^UTILITY(U,$J,358.3,23542,0)
 ;;=99205^^149^1341^5
 ;;^UTILITY(U,$J,358.3,23542,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23542,1,1,0)
 ;;=1^Comprehensive-High Complex
 ;;^UTILITY(U,$J,358.3,23542,1,2,0)
 ;;=2^99205
 ;;^UTILITY(U,$J,358.3,23543,0)
 ;;=99212^^149^1342^5
 ;;^UTILITY(U,$J,358.3,23543,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23543,1,1,0)
 ;;=1^Problem Focused 
 ;;^UTILITY(U,$J,358.3,23543,1,2,0)
 ;;=2^99212
 ;;^UTILITY(U,$J,358.3,23544,0)
 ;;=99213^^149^1342^4
 ;;^UTILITY(U,$J,358.3,23544,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23544,1,1,0)
 ;;=1^Expanded Prob Focused 
 ;;^UTILITY(U,$J,358.3,23544,1,2,0)
 ;;=2^99213
 ;;^UTILITY(U,$J,358.3,23545,0)
 ;;=99214^^149^1342^3
 ;;^UTILITY(U,$J,358.3,23545,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23545,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,23545,1,2,0)
 ;;=2^99214
 ;;^UTILITY(U,$J,358.3,23546,0)
 ;;=99215^^149^1342^2
 ;;^UTILITY(U,$J,358.3,23546,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23546,1,1,0)
 ;;=1^Comprehensive 
 ;;^UTILITY(U,$J,358.3,23546,1,2,0)
 ;;=2^99215
 ;;^UTILITY(U,$J,358.3,23547,0)
 ;;=99211^^149^1342^1
 ;;^UTILITY(U,$J,358.3,23547,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23547,1,1,0)
 ;;=1^Brief Visit
 ;;^UTILITY(U,$J,358.3,23547,1,2,0)
 ;;=2^99211
 ;;^UTILITY(U,$J,358.3,23548,0)
 ;;=99241^^149^1343^1
 ;;^UTILITY(U,$J,358.3,23548,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23548,1,1,0)
 ;;=1^Problem Focused
 ;;^UTILITY(U,$J,358.3,23548,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,23549,0)
 ;;=99242^^149^1343^2
 ;;^UTILITY(U,$J,358.3,23549,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23549,1,1,0)
 ;;=1^Expanded Problem Focused
 ;;^UTILITY(U,$J,358.3,23549,1,2,0)
 ;;=2^99242
 ;;^UTILITY(U,$J,358.3,23550,0)
 ;;=99243^^149^1343^3
 ;;^UTILITY(U,$J,358.3,23550,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23550,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,23550,1,2,0)
 ;;=2^99243
 ;;^UTILITY(U,$J,358.3,23551,0)
 ;;=99244^^149^1343^4
 ;;^UTILITY(U,$J,358.3,23551,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23551,1,1,0)
 ;;=1^Comprehensive - Moderate
 ;;^UTILITY(U,$J,358.3,23551,1,2,0)
 ;;=2^99244
 ;;^UTILITY(U,$J,358.3,23552,0)
 ;;=99245^^149^1343^5
 ;;^UTILITY(U,$J,358.3,23552,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,23552,1,1,0)
 ;;=1^Comprehensive - High
 ;;^UTILITY(U,$J,358.3,23552,1,2,0)
 ;;=2^99245
 ;;^UTILITY(U,$J,358.3,23553,0)
 ;;=581.81^^150^1344^15
 ;;^UTILITY(U,$J,358.3,23553,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23553,1,4,0)
 ;;=4^581.81
 ;;^UTILITY(U,$J,358.3,23553,1,5,0)
 ;;=5^Nephrotic Syndrome
 ;;^UTILITY(U,$J,358.3,23553,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,23554,0)
 ;;=583.81^^150^1344^14
 ;;^UTILITY(U,$J,358.3,23554,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23554,1,4,0)
 ;;=4^583.81
 ;;^UTILITY(U,$J,358.3,23554,1,5,0)
 ;;=5^Nephritis
 ;;^UTILITY(U,$J,358.3,23554,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,23555,0)
 ;;=710.1^^150^1344^23
 ;;^UTILITY(U,$J,358.3,23555,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23555,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,23555,1,5,0)
 ;;=5^Systemic Sclerosis (Sclero Derma)
 ;;^UTILITY(U,$J,358.3,23555,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,23556,0)
 ;;=710.2^^150^1344^11
 ;;^UTILITY(U,$J,358.3,23556,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23556,1,4,0)
 ;;=4^710.2
 ;;^UTILITY(U,$J,358.3,23556,1,5,0)
 ;;=5^Keratoconjuctiviis Sicca(Sjogren)
 ;;^UTILITY(U,$J,358.3,23556,2)
 ;;=^192145
 ;;^UTILITY(U,$J,358.3,23557,0)
 ;;=710.3^^150^1344^2
 ;;^UTILITY(U,$J,358.3,23557,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23557,1,4,0)
 ;;=4^710.3
 ;;^UTILITY(U,$J,358.3,23557,1,5,0)
 ;;=5^Dermatomyositis
 ;;^UTILITY(U,$J,358.3,23557,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,23558,0)
 ;;=710.4^^150^1344^17
 ;;^UTILITY(U,$J,358.3,23558,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23558,1,4,0)
 ;;=4^710.4
 ;;^UTILITY(U,$J,358.3,23558,1,5,0)
 ;;=5^Polymyositis
 ;;^UTILITY(U,$J,358.3,23558,2)
 ;;=^186822
 ;;^UTILITY(U,$J,358.3,23559,0)
 ;;=710.9^^150^1344^1
 ;;^UTILITY(U,$J,358.3,23559,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23559,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,23559,1,5,0)
 ;;=5^Connective Tissue Disease Unsp
 ;;^UTILITY(U,$J,358.3,23559,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,23560,0)
 ;;=443.0^^150^1344^19
 ;;^UTILITY(U,$J,358.3,23560,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23560,1,4,0)
 ;;=4^443.0
 ;;^UTILITY(U,$J,358.3,23560,1,5,0)
 ;;=5^Raynaud's Syndrome
 ;;^UTILITY(U,$J,358.3,23560,2)
 ;;=^103165
 ;;^UTILITY(U,$J,358.3,23561,0)
 ;;=714.0^^150^1344^21
 ;;^UTILITY(U,$J,358.3,23561,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23561,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,23561,1,5,0)
 ;;=5^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,23561,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,23562,0)
 ;;=714.9^^150^1344^10
 ;;^UTILITY(U,$J,358.3,23562,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23562,1,4,0)
 ;;=4^714.9
 ;;^UTILITY(U,$J,358.3,23562,1,5,0)
 ;;=5^Inflammatory Arth., Seronegative
 ;;^UTILITY(U,$J,358.3,23562,2)
 ;;=^272122
 ;;^UTILITY(U,$J,358.3,23563,0)
 ;;=274.9^^150^1344^4
 ;;^UTILITY(U,$J,358.3,23563,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23563,1,4,0)
 ;;=4^274.9
 ;;^UTILITY(U,$J,358.3,23563,1,5,0)
 ;;=5^Gout Nos
 ;;^UTILITY(U,$J,358.3,23563,2)
 ;;=^52625
 ;;^UTILITY(U,$J,358.3,23564,0)
 ;;=733.40^^150^1344^13
 ;;^UTILITY(U,$J,358.3,23564,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23564,1,4,0)
 ;;=4^733.40
 ;;^UTILITY(U,$J,358.3,23564,1,5,0)
 ;;=5^Necrosis/Aseptic
 ;;^UTILITY(U,$J,358.3,23564,2)
 ;;=^81763
 ;;^UTILITY(U,$J,358.3,23565,0)
 ;;=734.^^150^1344^16
 ;;^UTILITY(U,$J,358.3,23565,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23565,1,4,0)
 ;;=4^734.
 ;;^UTILITY(U,$J,358.3,23565,1,5,0)
 ;;=5^Pes Planus
 ;;^UTILITY(U,$J,358.3,23565,2)
 ;;=^46756
 ;;^UTILITY(U,$J,358.3,23566,0)
 ;;=736.70^^150^1344^18
 ;;^UTILITY(U,$J,358.3,23566,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23566,1,4,0)
 ;;=4^736.70
 ;;^UTILITY(U,$J,358.3,23566,1,5,0)
 ;;=5^Pronated Feet
 ;;^UTILITY(U,$J,358.3,23566,2)
 ;;=^123805
 ;;^UTILITY(U,$J,358.3,23567,0)
 ;;=337.20^^150^1344^20
 ;;^UTILITY(U,$J,358.3,23567,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23567,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,23567,1,5,0)
 ;;=5^Reflex Sympathetic Dystrophy-Unsp
 ;;^UTILITY(U,$J,358.3,23567,2)
 ;;=^295799
 ;;^UTILITY(U,$J,358.3,23568,0)
 ;;=710.0^^150^1344^22
 ;;^UTILITY(U,$J,358.3,23568,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23568,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,23568,1,5,0)
 ;;=5^Syst Lupus Erythematosis
 ;;^UTILITY(U,$J,358.3,23568,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,23569,0)
 ;;=695.4^^150^1344^3
 ;;^UTILITY(U,$J,358.3,23569,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23569,1,4,0)
 ;;=4^695.4
 ;;^UTILITY(U,$J,358.3,23569,1,5,0)
 ;;=5^Discoid Lupus
 ;;^UTILITY(U,$J,358.3,23569,2)
 ;;=^72141
 ;;^UTILITY(U,$J,358.3,23570,0)
 ;;=359.6^^150^1344^9
 ;;^UTILITY(U,$J,358.3,23570,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23570,1,4,0)
 ;;=4^359.6
 ;;^UTILITY(U,$J,358.3,23570,1,5,0)
 ;;=5^Infl Myopathy In Oth Dis
